Mankind Pharma:- About the company
Incorporated in 1991, Mankind pharma is one of India’s largest pharmaceutical company companies (by domestic sales) based in New Delhi, India.
The company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products like condoms, antibiotics, and gastrointestinal and erectile dysfunction drugs.
The company sells 36 brands under its umbrella,19 brands out of the 20 highest-selling brands are ranked among the three highest-selling brands in their respective molecule group in the IPM, 21 of the brands are among the 300 highest-selling brands of the IPM(source: IQVIA MAT Dec 2022).
The company is one of the largest distribution networks of medical representatives in the Indian pharmaceutical market. Over 80% of doctors in India prescribed their formation and has been ranked number 4th in terms of domestic sales during the Financial Year 2022.
Awards & Recognition of the company:-
- EHS Best Practices award at Greentech International EHS Award 2023.
- E4m Pride of India – The Best of Bharat Awards 2022 by exchange4media.
- Award for Branding and Marketing Excellence for the Strategic Initiative to Introduce DMF Quality Drugs in India at National Awards for Leadership & Excellence 2022.
- Silver Award for Good Health Brand at IHW Awards 2021.
Mankind Pharma IPO Details :-
The Initial Public Offering (IPO) of Mankind Pharma worth Rs.4,326.36 crore is set to open for subscription from Tuesday, April 25, 2023 and will remain open till Thursday, April 27, 2023.
The public issue is completely offer for sale (OFS). The price band for the IPO is fixed at Rs.1026 to Rs.1080 per share. The minimum lot size for retail investors is 13 shares.
According to market observers, Mankind Pharma shares are available at a premium of Rs. 76 per equity share in the grey market today.
Mankind Pharma IPO Details :-
| IPO DATE | Apr 25 , 2023 to Apr 27 ,2023 |
|---|---|
| Face Value | Rs. 1 per share |
| Price Band | Rs. 1026 to Rs.1080 per share |
| Lot Size (Min. Amount) | 13 shares (Rs.14,040/-) |
| Issuse Size | 40,058,844 shares(aggregating upto Rs.4,326,36 cr OFS) |
| Listing at | NSE , BSE |
| Lead Manager | Kotak Mahindra Capital Axis Capital Limited IIFL Securities Ltd. Jefferies India Pvt. Ltd. J.P. Morgan India Pvt. Ltd. |
| Registrar | KFin Technologies Ltd. |
Mankind Pharma IPO Tentative Dates:-
| EVENT | Tentative Date |
|---|---|
| Opening Date | Apr 25 , 2023 |
| Closing Date | Apr 27 , 2023 |
| Allotment Date | May 03 , 2023 |
| Initiation of Refund | May 04 , 2023 |
| Credit of Shares to demat | May 05 , 2023 |
| Listing Date | May 09 , 2023 |
Mankind Pharma: Strengths & Weakness:-
Strengths:-
- The company is focused on the domestic market with a growth of 20% CAGR.
- It has the largest medical representative team which helps the company’s distribution network.
- The company has a well-diversified portfolio of therapeutic medications that include antibiotics,cardiovascular, and neuro medications.
- The company has established a number of brands in the consumer healthcare segment with condoms, and pregnancy detection, among others that have a strong brand recall.
Weakness:-
- The company has a high attrition rate which may affect the distribution network.
- The business of the company is highly dependent on the Indian market.
- Any new Government regulating policies may affect the business.
Mankind Pharma: Financial Snapshots:-
| Particulars(in Rs. Crores) | FY-2022 | FY-2021 | FY-2020 |
|---|---|---|---|
| Total Assests | 9147.7 | 6372.6 | 5073.3 |
| Revenue from Operations | 7781.6 | 6214.4 | 5865.2 |
| EBITA | 2003.8 | 1659.8 | 1448.3 |
| EBITA Growth | 20.73% | 14.60% | |
| PAT | 1453.0 | 1293.0 | 1056.1 |
| PAT Margin | 18.67% | 20.81% | 18.01% |
| Debt | 208 | 156.34 | 143.12 |
Valuation :
Shareholding Pattern :
| Earning Per Share (EPS) | Rs. 33.20/- |
|---|---|
| P/E Ratio | 32.5 |
| RoNW | 27.7% |
| Net Asset Value(NAV) As on 31.12.22 | Rs.178.38 |
| Shareholding | Pre Issu % | Post Issue % |
|---|---|---|
| Promoter & Promoter Group | 79.00 | 76.50 |
| Public & Employee | 21.00 | 23.50 |
| Total | 100.0 | 100.0 |
How to apply for Mankind Pharma IPO:-
After analyzing all the risks, strengths, and finances of the company.If you think you should apply for this IPO, here are the steps that you need to follow:
- Log into your Upstox account,using your six-digit PIN.
- After logging in , click on “Discover”
- On the “Discover” tab, you will find the “Invest in IPO” section.
- Under the “Invest in IPO” section, look for the ‘Mankind Pharma IPO‘ tab and click on it.
- Now fill in all the required information, like ‘bid price’ and ‘lot size’.
- Confirm and click on “Apply”.
- Accept the mandate on your UPI app.